naringinase

consists of rhamnosidase (EC 3.2.1.40) & BETA-GLUCOSIDASES (EC 3.2.1.21); used to remove rhamnose & glucose from naringin & other glycosides to obtain aglycones

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Chen, Lianghua: 1 article (09/2018)
2.	Huang, Wen: 1 article (09/2018)
3.	Lin, Hetong: 1 article (09/2018)
4.	Lin, Mengshi: 1 article (09/2018)
5.	Ming, Yanlin: 1 article (09/2018)
6.	Xiao, Jianbo: 1 article (09/2018)
7.	Zheng, Yi: 1 article (09/2018)
8.	Zheng, Zhizhong: 1 article (09/2018)
9.	Arnhold, Juegen: 1 article (03/2010)
10.	Bouriche, Hamama: 1 article (03/2010)

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 09/01/2018 - "The enzymatic conversion of gyp XLVI by naringinase, and the cytotoxicity of enzymolysis product on SMMC7721 and Bel7402 hepatoma cells were investigated. " 09/01/2018 - "Gynosaponin TN-1 producing from the enzymatic conversion of gypenoside XLVI by naringinase and its cytotoxicity on hepatoma cell lines."
2.	Chronic Disease (Chronic Diseases) 03/01/2010 - "arabica leaf extract treated with naringinase to reduce chemotaxis in human neutrophils may be an important therapeutic factor in the treatment of chronic diseases."

Related Drugs and Biologics

1.	gynosaponin TN-1
2.	gypenoside XLVI